Related Experiment Videos
Barbiturate-induced transmitter release at a frog neuromuscular junction
British Journal of Pharmacology
|May 1, 1973
Summary
Barbiturates like CHEB and phenobarbitone alter neuromuscular transmission by increasing quantum content and decreasing miniature end-plate potential amplitude. These drugs also prolong nerve-terminal action potential duration.
Area of Science:
- Neuroscience
- Pharmacology
- Muscle Physiology
Background:
- Barbiturates are known central nervous system depressants.
- Their effects on neuromuscular junctions, particularly under specific ionic conditions, require further elucidation.
Purpose of the Study:
- To investigate the electrophysiological effects of barbiturates on neuromuscular transmission.
- To compare the actions of a convulsant barbiturate (CHEB) with phenobarbitone at the frog neuromuscular junction.
Main Methods:
- Electrophysiological recordings were performed on frog sartorius muscle preparations.
- Solutions used were low in calcium and high in magnesium to modulate synaptic transmission.
Main Results:
- Both CHEB and phenobarbitone increased the mean quantum content of end-plate potentials.
- A decrease in the mean amplitude of miniature end-plate potentials was observed with both drugs.
- Barbiturates prolonged nerve-terminal action potential duration without significantly affecting muscle membrane resistance.
Conclusions:
- Barbiturates modulate neurotransmitter release at the neuromuscular junction.
- The observed effects suggest a presynaptic mechanism of action for these barbiturates.